Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date13 Apr 2020 |
100 Clinical Results associated with Hebei Wanbang Fu Lin Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Hebei Wanbang Fu Lin Pharmaceutical Co. Ltd.
100 Deals associated with Hebei Wanbang Fu Lin Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Hebei Wanbang Fu Lin Pharmaceutical Co. Ltd.